Europe’s Stoxx 600 inches lower amid French political crisis
Willis Towers Watson PLC (WTW) stock reached a significant milestone, achieving an all-time high of $344.17, with a market capitalization of $33.54 billion. According to InvestingPro analysis, the stock appears slightly overvalued at current levels. This peak underscores a robust performance, with the stock delivering a 19.23% return over the past year and a 9.44% gain year-to-date. The insurance and advisory firm’s stock has been on an upward trajectory, supported by analyst optimism with price targets ranging from $305 to $408, and a strong dividend track record spanning 23 consecutive years. This all-time high marks a pivotal moment for Willis Towers Watson, as it continues to navigate the competitive landscape of the insurance and risk management industry. InvestingPro subscribers can access 8 additional key insights and a comprehensive Pro Research Report, offering deep-dive analysis of WTW’s financial health and growth prospects.
In other recent news, WTW has announced a $1.5 billion increase to its share repurchase program, adding to the $200 million remaining from its current authorization. This brings the total available funds for buybacks to $1.7 billion. Meanwhile, WTW’s Commercial Lines Insurance Pricing Survey reported a 3.8% increase in U.S. commercial insurance rates for the second quarter of 2025, marking a slowdown from the 5.3% rise in the first quarter. Additionally, Willis, a WTW business, has made strategic hires, appointing Gina Mulhall as Head of Global Portfolio Solutions to enhance its Placement and Portfolio Solutions team. Leadership changes have also been announced within Willis’s Global Construction and Global Surety teams, with Bill Creedon transitioning to the role of Chairman to focus on client engagement and talent development. Furthermore, Evercore ISI has raised its price target for Willis Towers Watson to $373, maintaining an Outperform rating. The firm cites improved earnings per share estimates, slightly better margins, and Health growth as factors for the revised target. These developments reflect WTW’s strategic initiatives and market positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.